Levi A. Garraway

Affiliations: 
Biology: Medical Sciences, Division of Harvard University, Cambridge, MA, United States 
Area:
Molecular Biology, Bioinformatics Biology
Google:
"Levi Garraway"

Children

Sign in to add trainee
Jeff Meng grad student (Neurotree)
Eliezer M. Van Allen grad student (Neurotree)
Sylvan C. Baca grad student 2013 Harvard
Nikhil Wagle post-doc
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Rendo V, Schubert M, Khuu N, et al. (2025) A compendium of Amplification-Related Gain Of Sensitivity genes in human cancer. Nature Communications. 16: 1077
Medford AJ, Carmeli AB, Ritchie A, et al. (2024) A standing platform for cancer drug development using ctDNA-based evidence of recurrence. Nature Reviews. Cancer
Hodis E, Triglia ET, Kwon JYH, et al. (2022) Stepwise-edited, human melanoma models reveal mutations' effect on tumor and microenvironment. Science (New York, N.Y.). 376: eabi8175
Creasy CA, Meng YJ, Forget MA, et al. (2022) Genomic Correlates of Outcome in Tumor-Infiltrating Lymphocyte Therapy for Metastatic Melanoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research
Stover EH, Oh C, Keskula P, et al. (2022) Implementation of a prostate cancer-specific targeted sequencing panel for credentialing of patient-derived cell lines and genomic characterization of patient samples. The Prostate
Zaidi SH, Harrison TA, Phipps AI, et al. (2020) Landscape of somatic single nucleotide variants and indels in colorectal cancer and impact on survival. Nature Communications. 11: 3644
Izar B, Tirosh I, Stover EH, et al. (2020) A single-cell landscape of high-grade serous ovarian cancer. Nature Medicine
Liu D, Schilling B, Liu D, et al. (2020) Author Correction: Integrative molecular and clinical modeling of clinical outcomes to PD1 blockade in patients with metastatic melanoma. Nature Medicine
Wander SA, Cohen O, Gong X, et al. (2020) The genomic landscape of intrinsic and acquired resistance to cyclin-dependent kinase 4/6 inhibitors in patients with hormone receptor positive metastatic breast cancer. Cancer Discovery
Nusinow DP, Szpyt J, Ghandi M, et al. (2020) Quantitative Proteomics of the Cancer Cell Line Encyclopedia. Cell. 180: 387-402.e16
See more...